Drug intelligence / Profile preview

Q-Vit Antioxidant Multivitamin

Development stage: Unknown
Lead developer: Niner Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Q-Vit Antioxidant Multivitamin is a combination pharmaceutical product developed and marketed by Niner Pharmaceuticals. It is formulated as oral tablets containing a blend of vitamins and antioxidant agents intended to supplement nutritional intake and mitigate cellular damage caused by oxidative stress. As a trade product in Niner Pharmaceuticals' portfolio, it is positioned as a finished pharmaceutical product for the management of nutritional deficiencies and the promotion of general health. The specific composition typically includes essential vitamins and minerals that act as enzymatic cofactors and free radical scavengers.

Brand names: Q-Vit Antioxidant MultivitaminQ-Vit Antioxidant Multivitamin Tablets
Other names: Q-Vit

Beyond the preview

Go deeper on Q-Vit Antioxidant Multivitamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Q-Vit Antioxidant Multivitamin.

Explore the full profile